Reveals where prescription drugs come from and go

File S09985 ("Reveals where prescription drugs come from and go") is before the New York Legislature and has not been decided. Latest step (April 21, 2026): In Senate Committee.

New York file S09985, before the New York Legislature. Still to be decided as of 2026-04-21.

What it does

Request drug supply chain origin and distribution details Upon request to a pharmacy benefit manager, you would gain access to information about where your prescription drugs originated, who manufactured them, and how they were distributed to your pharmacy.

The bigger picture

Increased visibility may deter counterfeit drugs in distribution Enhanced transparency requirements could reduce opportunities for counterfeit or diverted medications to enter legitimate pharmacy networks by making the supply chain more trackable and accountable.

What to watch

Pharmacy benefit managers bear compliance costs and burden PBMs must maintain and produce supply chain records on demand, which may increase operational costs and could delay responses to patient requests if systems are not designed to handle the requirement.

Official summary

Enacts the "foreign drug transparency act" to provide information on the origin, manufacture and distribution of prescription drugs; requires a pharmacy benefit manager to maintain, and make available to pharmacies, health plans, and patients upon request, supply chain information for prescription drugs covered under its network.

Read the official record for S09985

See everything up for a vote · This week in New York · See what we have filed with the clerk